Benzinga | Mar 16, 2021 04:03PM EDT

Kindred Biosciences Q4 EPS $(0.28) Beats $(0.29) Estimate, Sales $1.00M Inline

Kindred Biosciences (NASDAQ:KIN) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.29) by 3.45 percent. This is a 30 percent increase over losses of $(0.40) per share from the same period last year. The company reported quarterly sales of $1.00 million which met the analyst consensus estimate. This is a 28.62 percent decrease over sales of $1.40 million the same period last year.